Event

The recent CMS SEP-1 core measure, Sepsis-3 definitions, and cutting edge research will shape the future of sepsis over the coming years. This session will reflect the unique location of the annual International ATS Conference this year by including talks discussing the development and future of SEP-1, the concerns voiced by major societies regarding this measure, and how the readmission reduction programs can be leveraged to improve the lives of sepsis survivors. The session will also highlight how the new sepsis definitions could impact future clinical trial design and bedside care. Finally, new research that will bring precision medicine to septic patients will be discussed.